Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-19

Clinical Trial Update: Modulation of the Gut Microbiota and Metabolism in Elderly by Algae Products. [NA]

View source ↗

Summary

Clinical trial assessing whether algae-derived products modulate gut microbiota and metabolism in older adults with frailty. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Algae-derived product supplement

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Frailty | NA | Status: COMPLETED